Cutler Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
DC
RJFSA
SFS
NAM
Cutler Group's SBIO Position: Q2 2023 in Review
Cutler Group sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2023, closing a stake of 280 shares — an estimated $8.7K sold.
Cutler Group first reported a position in SBIO in Q4 2015 and held it in 17 quarters. The position peaked at $97K in Q4 2020. 41 funds tracked by Wall St. Rank hold SBIO as of Q2 2023.
- Cutler Group reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2023 after selling out during the quarter.
- Cutler Group sold 280 ALPS Medical Breakthroughs ETF shares in Q2 2023, an estimated $8.7K.
- Cutler Group first reported a position in ALPS Medical Breakthroughs ETF in Q4 2015 and held it in 17 quarters.
- Cutler Group's ALPS Medical Breakthroughs ETF position peaked at $97K in Q4 2020.
- 41 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2023.
Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.